Abstract
The same total dose (1.2 g/kg/week) of 2,5-hexanedione (2,5-HD) was administered subcutaneously at 100 mg/kg/12 hr, 200 mg/kg/24 hr, and 400 mg/kg/48 hr to three groups of Donryu rats. The peripheral neuropathy induced by 2,5-HD was confirmed by clinical observation every day, and neurophysiological measurements every 4 weeks. During the 15th week of this experiment, 2,5-HD concentrations in plasma 0.5 to 24 hours after injection were determined. It was found that the greater the dose of 2,5-HD per treatment injected, the earlier peripheral neuropathy developed. Toxicokinetic analysis showed that both the values of the area under the plasma concentration versus time curve and the half life of 2,5-HD were increased, but the excretion parameters (Ke) were decreased, in animals treated with 200 mg/kg/24 hr and 400 mg/kg/48 hr 2,5-HD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Spencer, P. S., and Schaumburg, H. H. 1975. Experimental neuropathy produced by 2,5-hexanedion—a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J. Neurol. Neurosurg. 38:771–775.
Spencer, P. S., Bischoff, M. S., and Schaunburg, H. H. 1978. On the molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral distal axonopathy. Toxicol. Appl. Pharmacol. 44:17–28.
Takeuchi, Y., Hisanaga, N., Ono, Y., and Inoue, T. 1980. Toxicity and dose-response relationship of n-hexane. Jpn. J. Ind. Health. 22:470–487.
Pryor, G. T., Bingham, L. R., Dickinson, J., Robert, C. S., and Howd, R. A. 1982. Importance of schedule of exposure to hexane in causing neuropathy. Neurobehavioral Toxicol. Teratol. 4:71–78.
Nagano, M., Misimi, J., and Nomura, S. 1983. An electrophysiological study on peripheral neuropathy of 2,3-butanedione, 2,4-pentanedione and 2,5-hexanedione in rats. Jpn. J. Health. 25:471–482.
Yasui, Y., Zhao, W., Misumi, J., Aoki, K., Shimaoka, A., and Kudo, M. 1995. Influence of different doses of methyl ethyl ketone on 2,5-hexanedione concentrations in the sciatic nerve, serum, and urine of rats. J. Occup. Health. 37:19–24.
Aoki, K., Zhao, W., Misumi, J., Yasui, Y., and Kudo, M. 1996. Concentration changes in 2,5-hexanedione induced by combination treatment with methyl ethyl ketone or acetone in the sciatic nerve, serum and urine of rats. J. Occup. Health. 38:30–35.
Zhao, W., Yasui, Y., Misumi, J., Aoki, K., Shimaoka, A., Goto, T., Kurakake, S., and Suemune, J. 1995. Influence of co-administration with different doses of methyl ethyl ketone, acetone and toluene on the 2,5-hexanedione concentration in serum, nerve and urine. J. Occup. Health. 37(supplement): s452.
Misumi, J., and Nagano, M. 1984. Neurophysiological studies on the relationship between structural properties and neuropathy of aliphatic hydrocarbons in rats. Brit. J. Ind. Med. 41:526–532.
Misumi, J. 1979. Electrophysiological studies in vivo on peripheral nerve function and their application to peripheral nerve function and their application to peripheral neuropathy produced by organic mercury in rats. II Measurement of the maximum conduction velocity of compound action potentials in the tail nerve of healthy rats. Kumamoto Med. J. 32:1–14.
Brown, R. D., and Manno, J. E. 1978. Estrip, a basic computer program for obtaining initial polyexponential parameter estimates. J. Pharm. Sci. 67:1687–1691.
Yoshimura, S., Imai, K., Saitoh, Y., and Ohtaki, S. 1992. The same chemicals induce different neurotoxicity when administered in high doses for short term of low doses for long term to rats and dogs. Mol. Chem. Neuropatho. 16:59–84.
Baker, T. S., and Rickert, D. E. 1981. Dose-dependent uptake, distribution, and elimination of inhaled n-hexane in the Fischer-344 rats. Toxicol. Appl. Phramcol. 61:414–422.
Fedtke, N., and Bolt, H. M. 1987. The relevance of 4,5-dihydroxy-2-hexanone in the excretion kinetics of n-hexane metabolites in rat and man. Arch. Toxicol. 61:131–137.
Toftgard, R., Haaparanta, T., Halpert, J., and Halperi, J. 1986. Rat lung and liver microsomal cytochrome P-450 isozymes involved in the hydroxylation of n-hexane. Biochemical Pharmacology. 35:3733–3738.
Bos, O. M. J., Mik, G. D., and Bragt, P. C. 1991. Critical review of the toxicity of methyl n-butyl ketone from occupational exposure. Am. J. Ind. Med. 20:175–194.
Duguay, A. B., and Plaa, G. L. 1995. Tissue concentrations of methyl iosbutyl ketone, methyl n-butyl ketone and their metabolites after oral or inhalation exposure. Toxic. Letters. 75:51–58.
Robertson, P. Jr., White, E. L., and Bus, J. S. 1989. Effects of methyl ethyl ketone pretreatment on hepatic mixed-function oxidase activity and on in vivo metabolism of n-hexane. Xenobiotica. 19:721–729.
Harada, K., Nagano, M., Misumi, J., and Miura, H. 1989. Combined effects of methyl n-butyl ketone and methyl ethyl ketone on activities of microsomal drug metabolizing enzymes in rats. Jpn. J. Ind. Health. 31:156–157.
Suwita, E., Nomeir, A. A., and Abou-Donia, M. B. 1987. Disposition, pharmacokinetics and metabolism of a dermal dose of [14C] 2,5-hexanedione in hens. Drug Metabolism and Deposition. 15:779–785.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Misumi, J., Nagano, M., Futatsuka, M. et al. Different Administration Schedules of the Same Dose of 2,5-Hexanedione Influence the Development of Neuropathy and the Toxicokinetics. Neurochem Res 22, 27–32 (1997). https://doi.org/10.1023/A:1027317002386
Issue Date:
DOI: https://doi.org/10.1023/A:1027317002386